ConductScience.org, home

Paper413795

Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.

Heymès R and 2 others. Infection, 1977. Cited by 72 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study. Papers, record 413795. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/413795

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Experimental evaluation of HR756, a new cephalosporin derivative: pre-clinical study.
PubMed
Journal
Infection
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
72
iCite
Relative citation ratio, by iCite
4.43
iCite
Revised in PubMed
2019-08-27
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heymès RR
2Lutz AA
3Schrinner EE

Source PubMed

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CephalosporinsMajor topic
Animals
Dogs
Enterobacteriaceae
Klebsiella Infections
Mice
Microbial Sensitivity Tests
Pseudomonas aeruginosa
Pyelonephritis
Rats
Staphylococcal Infections
Streptococcal Infections

Source PubMed

Cited by25

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 72 citations.

PMIDTitleJournalYearIn PapersSource
10,319,137Synthesis and antibacterial activity of new cephalosporins with lactonyloxyimino moiety.Arch Pharm Res1994https://conductscience.org/library/papers/10319137PubMed
7,843,824The antimicrobial activity of cefotaxime: comparative multinational hospital isolate surveys covering 15 years.Infection1994https://conductscience.org/library/papers/7843824PubMed
7,247,361Activity of a new cephalosporin antibiotic, Ro 13-9904 against dense populations of selected enterobacteria.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247361PubMed
6,994,642GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6994642PubMed
6,972,728Comparison of in vitro activities of eight beta-lactamase-stable cephalosporins against beta-lactamase-producing gram-negative bacilli.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/6972728PubMed
6,972,194Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6972194PubMed
6,601,470In vitro antibacterial activity of SM-1652, a new broad-spectrum cephalosporin with antipseudomonal activity.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6601470PubMed
6,293,977Comparative beta-lactamase hydrolysis of and inhibition by 7-aminothiazolyl alpha-methoxyimino cephalosporins.Infection1982https://conductscience.org/library/papers/6293977PubMed
6,289,734Ceftriaxone: in vitro studies and clinical evaluation.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6289734PubMed
6,252,829Comparative in vitro activities of cefotaxime and ceftizoxime (FK749): new cephalosporins with exceptional potency.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6252829PubMed
6,250,981Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function.Infection1980https://conductscience.org/library/papers/6250981PubMed
6,247,965Biosynthesis of peptidoglycan in Pseudomonas aeruginosa: comparison of the inhibitory effects of cefotaxime, its anti isomer, and the syn S-oxide compound.Antimicrob Agents Chemother1980https://conductscience.org/library/papers/6247965PubMed
6,212,596Cefoperazone disk diffusion susceptibility test: confirmation of the tentative interpretive criteria, Pseudomonas aeruginosa cross-resistance, and determination of quality control performance limits.J Clin Microbiol1982https://conductscience.org/library/papers/6212596PubMed
6,188,701Cefotaxime concentrations in prostatic tissue.Infection1983https://conductscience.org/library/papers/6188701PubMed
6,092,278Chemotherapeutic properties of the new cephalosporin antibiotic HR810 in laboratory animals.Infection1984https://conductscience.org/library/papers/6092278PubMed
2,504,597In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.Eur J Clin Microbiol Infect Dis1989https://conductscience.org/library/papers/2504597PubMed
526,000Pharmacokinetics of cefotaxime.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/526000PubMed
525,994Ceftizoxime (FK 749), a new parenteral cephalosporin: in vitro and in vivo antibacterial activities.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/525994PubMed
485,125Human pharmacology of cefotaxime (HR 756), a new cephalosporin.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/485125PubMed
478,651The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.Infection1979https://conductscience.org/library/papers/478651PubMed

See all 25 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/413795

GET https://conductscience.org/api/papers/v1/413795/cited_by?page=2